Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27795313 | 0.86 | ALDH1A1 (0.38) | KMT2AKDM4EALDH1A1 | |
| SCHEMBL28267678 | 0.85 | HDAC3 (0.32) | KMT2AKDM4EALDH1A1MAPT | |
| SCHEMBL7456171 | 0.82 | MGAM (0.38) | — | |
| SCHEMBL21611098 | 0.80 | DGKA (0.42) | SMN1; SMN2KMT2A | |
| SCHEMBL21611111 | 0.80 | DGKA (0.42) | SMN1; SMN2KMT2A | |
| SCHEMBL8656142 | 0.79 | — | — | |
| SCHEMBL28275692 | 0.77 | KDM4E (0.34) | KDM4E | |
| SCHEMBL28301898 | 0.77 | KDM4E (0.34) | KDM4E | |
| SCHEMBL28170502 | 0.76 | KDM4E (0.36) | HIF1AKDM4EALDH1A1MAPT | |
| SCHEMBL7930722 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11925689-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2024-03-12 | — | — | US | disclosed |
| US-20230009076-A1 | POLYOXAZOLINE-DRUG CONJUGATES WITH NOVEL PHARMACOKINETIC PROPERTIES | SERINA THERAPEUTICS, INC. (US) | 2023-01-12 | — | — | US | disclosed |
| US-20220193243-A1 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | SERINA THERAPEUTICS, INC. (US) | 2022-06-23 | — | — | US | disclosed |
| EP-3990026-A1 | POLYOXAZOLINE-DRUG CONJUGATES WITH NOVEL PHARMACOKINETIC PROPERTIES | Serina Therapeutics, Inc. (US) | 2022-05-04 | — | — | EP | disclosed |
| CN-114258309-A | Polyoxazoline-drug conjugates with novel pharmacokinetic properties | 塞瑞纳治疗公司 | 2022-03-29 | — | — | CN | disclosed |
| US-11213588-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2022-01-04 | — | — | US | disclosed |
| WO-2020264505-A1 | POLYOXAZOLINE-DRUG CONJUGATES WITH NOVEL PHARMACOKINETIC PROPERTIES | SERINA THERAPEUTICS, INC. (US) | 2020-12-30 | — | — | WO | disclosed |
| US-20190134208-A1 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | SERINA THERAPEUTICS (AL), INC. | 2019-05-09 | — | — | US | disclosed |
| US-10166294-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2019-01-01 | — | — | US | disclosed |
| CN-108025196-A | Water-In-Oil light screening composition with organic sunscreen actives | 莱雅公司 | 2018-05-11 | — | — | CN | disclosed |
| EP-2235090-B1 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | SERINA THERAPEUTICS INC (US) | 2013-09-04 | — | — | EP | disclosed |
| US-8501899-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-20120136123-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| US-20120123055-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-8110651-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2012-02-07 | — | — | US | disclosed |
| US-8101706-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20110009594-A1 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | SERINA THERAPEUTICS, INC. (US) | 2011-01-13 | — | — | US | disclosed |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2010-12-30 | — | — | US | disclosed |
| EP-2235090-A2 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | Serina Therapeutics, Inc. (US) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009089542-A2 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | SERINA THERAPEUTICS, INC. (US) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193243-A1 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | ERBB3, ERBB2, PANK2 | ESR1 3533/4885HIF1A 2673/4885SMN1; SMN2 2101/4885 |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | ESR1 3533/4885HIF1A 2673/4885SMN1; SMN2 2101/4885 |
| US-20230009076-A1 | POLYOXAZOLINE-DRUG CONJUGATES WITH NOVEL PHARMACOKINETIC PROPERTIES | CYP3A5, CYP2C19, CYP3A7 | ESR1 4157/4885HIF1A 4332/4885SMN1; SMN2 2938/4885 |
| US-10166294-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | ERBB3, ERBB2, PANK2 | ESR1 3533/4885HIF1A 2673/4885SMN1; SMN2 2101/4885 |
| US-20190134208-A1 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | ERBB3, ERBB2, PANK2 | ESR1 3533/4885HIF1A 2673/4885SMN1; SMN2 2101/4885 |
| US-11925689-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | ERBB3, ERBB2, PANK2 | ESR1 3533/4885HIF1A 2673/4885SMN1; SMN2 2101/4885 |
| US-11213588-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | ERBB3, ERBB2, PANK2 | ESR1 3533/4885HIF1A 2673/4885SMN1; SMN2 2101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.